Delivery Order SPE2DB20D9103-SPE2DB24FE7A7

Award Date 12/14/23
Potential Completion Date 1/8/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,126.98, is for the delivery of 4,565,563,472 doses of the YF-VAX 1 DOSE VIALS vaccine. The order has a completion date of September 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $13,917.75, is for the delivery of 4,567,459,527 doses of the YF-VAX 1 vaccine. The contract has an ultimate completion date of March 21, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of 4,563,373,107 doses of the YF-VAX vaccine, with a completion date of February 2, 2024 and a potential value of $2,817.45. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,126.98 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of YF-VAX 1-dose vials and has a completion date of June 26, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,269.80 contract is for the delivery of 4,565,860,548 units of the YF-VAX 1 dose vaccine, with a completion date of October 3, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 contract is for the supply of 4563347047 1-dose vials of the YF-VAX vaccine, with a completion date of January 24, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $54,730.00 and covers the delivery of 4,562,879 units of the YF-VAX 1 dose vaccine vials. The order was placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which provides a wide range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,491,255 units of the YF-VAX 1 dose vaccine. The contract has a completion date of January 22, 2024 and a potential value of $3,380.94. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA Troop Support Medical valued up to $5 million through December 2025 to supply a variety of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,772.79 firm fixed-price contract is to provide 4,566,637,211 units of the YF-VAX 1 dose vaccine to the DLA, with a period of performance through December 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,244,347 doses of the YF-VAX vaccine. The $2,817.45 order has a completion date of January 26, 2024 and was awarded on January 4, 2024. DMS Pharmaceutical Group holds multiple pharmaceutical supply contracts with the Defense Logistics Agency, including an indefinite delivery contract valued up to $5 million through December 2025 to provide a...
  • SPE2DB20D9103
    Indefinite Delivery Contract
  • SPE2DB20D9103-SPE2DB24FE7A7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of 4,563,153,330 units of the YF-VAX 1 dose vaccine. The contract, valued at $1,094.62, has an ultimate completion date of January 8, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense healthcare sites. The contract does not have a set-aside designation.

Generated 2/27/25, 9:57 AM